Cancer Gene Therapy
Combination Therapy Enhances Killing of Cholangiocarcinoma
Published in Cancer Weekly, July 21st, 1997
Cholangiocarcinoma is a tumor that is virtually incurable. The tumor is resistant to current surgical, chemical, and radiotherapeutic interventions.
L.C. Pederson and colleagues from the University of Alabama at Birmingham, tackled this obstacle from a multimethod standpoint. Results of their research were presented at the 97th Annual Meeting of the American Gastroenterological Association, held May 11-14, 1997, in Washington, DC.
"We applied the novel gene therapy strategy of local toxin gene conversion of prodrug to active antineoplastic...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (1997-07-21)
More Articles from Cancer Weekly
- Cancer Gene Therapy
bax-(alpha) Transfection Counteracts bcl-2 Expression, Induces Apoptosis - Cancer Gene Therapy
Combination Immunogene Therapy Effective In Glioblastoma Model - Cancer Gene Therapy
Suicide Gene Therapy for Bile Duct Cancer Explored in Murine Model - Brain Cancer
Researchers Link Brain Tumor Drug Resistance To Mismatch Repair Deficiency - Breast Cancer
Massachusetts State Cancer Mortality Rate Is Down - Breast Cancer (Angiogenesis)
Anti-Angiogenic Factor Found To Inhibit Human Cancer Growth in Mice - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
